TY - JOUR
T1 - Erratum
T2 - Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial (The Lancet (2010) 376(9753) (1647–1657) (S0140673610619241) (10.1016/S0140-6736(10)61924-1))
AU - Dondorp, Arjen M.
AU - Fanello, Caterina I.
AU - Hendriksen, Ilse Ce
AU - Gomes, Ermelinda
AU - Seni, Amir
AU - Chhaganlal, Kajal D.
AU - Bojang, Kalifa
AU - Olaosebikan, Rasaq
AU - Anunobi, Nkechinyere
AU - Maitland, Kathryn
AU - Kivaya, Esther
AU - Agbenyega, Tsiri
AU - Nguah, Samuel Blay
AU - Evans, Jennifer
AU - Gesase, Samwel
AU - Kahabuka, Catherine
AU - Mtove, George
AU - Nadjm, Behzad
AU - Deen, Jacqueline
AU - Mwanga-Amumpaire, Juliet
AU - Nansumba, Margaret
AU - Karema, Corine
AU - Umulisa, Noella
AU - Uwimana, Aline
AU - Mokuolu, Olugbenga A.
AU - Adedoyin, Olanrewaju T.
AU - Johnson, Wahab Br
AU - Tshefu, Antoinette K.
AU - Onyamboko, Marie A.
AU - Sakulthaew, Tharisara
AU - Ngum, Wirichada Pan
AU - Silamut, Kamolrat
AU - Stepniewska, Kasia
AU - Woodrow, Charles J.
AU - Bethell, Delia
AU - Wills, Bridget
AU - Oneko, Martina
AU - Peto, Tim E.
AU - Von Seidlein, Lorenz
AU - Day, Nicholas Pj
AU - White, Nicholas J.
N1 - Publisher Copyright:
© 2011 Elsevier Ltd
PY - 2011/1/8
Y1 - 2011/1/8
N2 - Dondorp AM, Fanello CI, Hendriksen ICE, et al, for the AQUAMAT group. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 2010; 376: 1647–57—In this Article (Nov 13), the row in table 2 for death or sequelae at 28 days in the quinine group should have been: 316/2695 (11·7%). In table 1, the data in parentheses for coma depth are IQR. The last line of the legend for figure 3 should have read: “I2 denotes the percentage of total variation across subgroups resulting from heterogeneity rather than chance, with the p value of significance”. The title of figure 5 should have read: “Meta-analysis of all randomised controlled trials that have compared mortality of severe malaria in patients treated with parenteral artesunate versus parenteral quinine12–16”. These corrections have been made to the online version as of Jan 7, 2011.
AB - Dondorp AM, Fanello CI, Hendriksen ICE, et al, for the AQUAMAT group. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 2010; 376: 1647–57—In this Article (Nov 13), the row in table 2 for death or sequelae at 28 days in the quinine group should have been: 316/2695 (11·7%). In table 1, the data in parentheses for coma depth are IQR. The last line of the legend for figure 3 should have read: “I2 denotes the percentage of total variation across subgroups resulting from heterogeneity rather than chance, with the p value of significance”. The title of figure 5 should have read: “Meta-analysis of all randomised controlled trials that have compared mortality of severe malaria in patients treated with parenteral artesunate versus parenteral quinine12–16”. These corrections have been made to the online version as of Jan 7, 2011.
UR - http://www.scopus.com/inward/record.url?scp=85038626703&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85038626703&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(11)60019-6
DO - 10.1016/S0140-6736(11)60019-6
M3 - Comment/debate
AN - SCOPUS:85038626703
SN - 0140-6736
VL - 377
SP - 126
JO - The Lancet
JF - The Lancet
IS - 9760
ER -